Marksans Pharma

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue157.35214.66220.60242.69237.39
Expenses134.51160.27176.10208.09198.99
EBITDA27.0159.3853.2343.3046.10
EBIT23.5154.6644.7334.8738.63
Profit Before Tax22.8554.3944.5034.6038.40
Net Profit17.8144.1931.2925.2932.99
Financial Ratios
Operating Profit Margin17.65%32.62%26.01%17.94%20.47%
Net Profit Margin11.64%24.27%15.29%10.48%14.65%
Earning Per Share (Diluted)0.430.980.690.560.73
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ